Yahoo!
My Yahoo!
Mail
Sign In
[New User?
Sign Up
]
Finance Home
|
Help
Wednesday, February 10, 2010, 5:22am EST - Canadian Markets open in 4 hours and 8 minutes.
To create a watchlist or portfolio of shares,
Sign-in
or
Register
Finance Home
Investing
Volume Leaders
Local Markets
US Markets
International Markets
Advances & Declines
ETFs
Income Trust News
News & Opinion
Markets
Industry
RSS-My Yahoo!
Personal Finance
Banking & Budgeting
Calculators
Insurance
Retirement
Taxes
My Portfolios
Sign In to Create/Edit My Portfolios
Get Quotes
Symbol Lookup
Exchanges
Abiomed Inc. (ABMD)
On Feb 9:
9.34 USD
0.00 (0.00%)
MORE ON ABMD
Quotes
Summary
Options
Historical Prices
Charts
Interactive
Basic Chart
Technical Chart
News & Info
Headlines
Company Events
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Star Analysts
Ownership
Major Holders
Insider Trans.
Insider Roster
Financials
Income Statement
Balance Sheets
Cash Flow
ABIOMED, Inc.
(NGM:ABMD) Delayed quote data
Last Trade:
9.34 USD
Trade Time:
Feb 9
Change:
0.00 (0.00%)
Prev Close:
9.34
Open:
N/A
Bid:
7.90
x 300
Ask:
N/A
1y Target Est:
10.83
Day's Range:
N/A - N/A
52wk Range:
4.67 - 11.25
Volume:
0
Avg Vol
(3m)
:
247,686
Market Cap:
350.11M
P/E
(ttm)
:
N/A
EPS
(ttm)
:
-0.78
Div & Yield:
N/A (N/A%)
1d
5d
3m
6m
1y
2y
5y
max
Add ABMD to Portfolio
Download Data
HEADLINES
Abiomed Beats Zacks Estimate
Zacks.com
(Mon, Feb 8)
New Star Analyst Rankings for ABIOMED, Inc.
StarMine
(Sat, Feb 6)
ABIOMED INC Files SEC form 10-Q, Quarterly Report
EDGAR Online
(Fri, Feb 5)
Abiomed fiscal 3Q loss narrows on Impella sales
AP
(Thu, Feb 4)
UPDATE - Abiomed posts narrower loss, trims FY revenue view
at Reuters
(Thu, Feb 4)
ABIOMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online
(Thu, Feb 4)
Abiomed Reports Third Quarter Fiscal 2010 Financial Results
Business Wire
(Thu, Feb 4)
Q3 2010 Abiomed, Inc. Earnings Release - Time Not Supplied
CCBN
(Thu, Feb 4)
Abiomed Third Fiscal Quarter 2010 Earnings and Conference Call Notification
Business Wire
(Thu, Jan 28)
Abiomed Announces Partnership with Opsens to Utilize Sensor Technology for Impella
Business Wire
(Wed, Jan 27)
Impella 2.5 Patient Procedure at Mount Sinai Medical Center Featuring New Product Enhancements: Webcast Available
Business Wire
(Mon, Jan 25)
More Headlines for ABMD...
ANALYST
EPS Est (next year)
(Mar-10)
:
-0.68
EPS Est (in 2 years)
(Mar-11)
:
-0.46
Avg Rec (current)*:
2.9
PEG Ratio:
N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion
-
Estimates
BUSINESS SUMMARY
Abiomed, Inc. and its subsidiaries manufacture and sell medical devices in circulatory support that offer a continuum of care in heart recovery to acute heart failure patients.
Full Company Profile
Add to Portfolio
Email to a Friend
Get
Summary
for Another Symbol:
Symbol Lookup
Latest News
Canadian Indices